{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Zug",
      "state": "N/A",
      "country": "Switzerland",
      "classification": "Class II",
      "openfda": {
        "application_number": [
          "ANDA212309"
        ],
        "brand_name": [
          "FOSAPREPITANT"
        ],
        "generic_name": [
          "FOSAPREPITANT"
        ],
        "manufacturer_name": [
          "BE Pharmaceuticals Inc."
        ],
        "product_ndc": [
          "71839-104"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "INTRAVENOUS"
        ],
        "substance_name": [
          "FOSAPREPITANT DIMEGLUMINE"
        ],
        "rxcui": [
          "1731077"
        ],
        "spl_id": [
          "1b1fe4ce-02d6-4ca1-8168-37b099caa434"
        ],
        "spl_set_id": [
          "21b08b87-70e3-4233-9531-dd6d84eab5d0"
        ],
        "package_ndc": [
          "71839-104-01"
        ],
        "is_original_packager": [
          true
        ],
        "upc": [
          "0371839104017"
        ],
        "unii": [
          "D35FM8T64X"
        ]
      },
      "product_type": "Drugs",
      "event_id": "93747",
      "recalling_firm": "BE PHARMACEUTICALS AG",
      "address_1": "Bundesstrasse 3",
      "address_2": "N/A",
      "postal_code": "N/A",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide in the USA",
      "recall_number": "D-0262-2024",
      "product_description": "Fosaprepitant for Injection 150 mg per vial, Sterile lyophilized powder for Intravenous use only after reconstitution and dilution, Single Dose Vial, Rx Only, Distributed by BE Pharmaceuticals Inc. 203 New Edition Court Cary, NC 27511, Made in India, NDC 71839-104-01.",
      "product_quantity": "22,176 Vials",
      "reason_for_recall": "Lack of Sterility Assurance: Aseptic process simulation failure.",
      "recall_initiation_date": "20240110",
      "center_classification_date": "20240125",
      "termination_date": "20250610",
      "report_date": "20240131",
      "code_info": "lot #13D012AA, Exp: 08/31/2025"
    }
  ]
}